Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 1
2015 1
2016 1
2018 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
Naranjo MG, Rodrigues-Soares F, Peñas-Lledó EM, Tarazona-Santos E, Fariñas H, Rodeiro I, Terán E, Grazina M, Moya GE, López-López M, Sarmiento AP, Calzadilla LR, Ramírez-Roa R, Ortiz-López R, Estévez-Carrizo FE, Sosa-Macías M, Barrantes R, LLerena A; CEIBA-Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF. Naranjo MG, et al. OMICS. 2018 Sep;22(9):575-588. doi: 10.1089/omi.2018.0114. Epub 2018 Sep 11. OMICS. 2018. PMID: 30183544
The RIBEF-CEIBA Network Consortium was established to characterize interindividual and between population variations in CYP2D6, CYP2C9, and CYP2C19 drug metabolizing enzyme genotypes, which were subsequently utilized to catalog their "predicted drug metabolis …
The RIBEF-CEIBA Network Consortium was established to characterize interindividual and between population variations in …
Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders.
Rodeiro I, Remírez-Figueredo D, García-Mesa M, Dorado P, LLerena A; CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF. Rodeiro I, et al. Drug Metabol Drug Interact. 2012;27(1):57-60. doi: 10.1515/dmdi-2012-0006. Drug Metabol Drug Interact. 2012. PMID: 22718626
Meeting report of the "Second Symposium on Pharmacology of Cytochrome P450 and Transporters" organized by the Cuban Society of Pharmacology in collaboration with the European Society of Pharmacogenetics and Theranostics (ESPT) and the Ibero-American Networ …
Meeting report of the "Second Symposium on Pharmacology of Cytochrome P450 and Transporters" organized by the Cuban Society of Pharmacology …
Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.
Céspedes-Garro C, Jiménez-Arce G, Naranjo ME, Barrantes R, Llerena A; CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics & Pharmacogenomics RIBEF. Céspedes-Garro C, et al. Rev Biol Trop. 2014 Dec;62(4):1659-71. Rev Biol Trop. 2014. PMID: 25720195
CYP2D6 differences have already been demonstrated within Latin American populations by the CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics (RIBEF, as per the acronym in Spanish). ...Additionally, these frequencies of …
CYP2D6 differences have already been demonstrated within Latin American populations by the CEIBA.FP Consortium of the Ibero …
Pharmacogenetics in Central American healthy volunteers: interethnic variability.
Céspedes-Garro C, Naranjo ME, Ramírez R, Serrano V, Fariñas H, Barrantes R, LLerena A; CEIBA Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF. Céspedes-Garro C, et al. Drug Metab Pers Ther. 2015 Mar;30(1):19-31. doi: 10.1515/dmdi-2014-0025. Drug Metab Pers Ther. 2015. PMID: 25490028 Review.
This study aims to describe the frequency of the most relevant pharmacogenetic biomarkers and metabolic phenotypes in Central American healthy volunteers and to determine its interethnic variability. ...Reports on Central American populations were also found for the CYP2C1 …
This study aims to describe the frequency of the most relevant pharmacogenetic biomarkers and metabolic phenotypes in Central America …
Characterization of CYP2D6 genotypes and metabolic profiles in the Portuguese population: pharmacogenetic implications.
Albuquerque J, Ribeiro C, Naranjo MEG, Llerena A, Grazina M; CEIBA.FP Consortium of the Ibero–American Network of Pharmacogenetics & Pharmacogenomics RIBEF §. Albuquerque J, et al. Per Med. 2013 Sep;10(7):709-718. doi: 10.2217/pme.13.56. Per Med. 2013. PMID: 29768760
These results allow the determination of the frequency of the most relevant CYP2D6 polymorphisms and the prediction of the enzyme metabolic activity, being of much importance for the CYP2D6 pharmacogenetics approach in the Portuguese population. The data presented here are …
These results allow the determination of the frequency of the most relevant CYP2D6 polymorphisms and the prediction of the enzyme metabolic …
Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population.
Céspedes-Garro C, Rodrigues-Soares F, Jiménez-Arce G, Naranjo MG, Tarazona-Santos E, Fariñas H, Barrantes R, Llerena A; CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics & Pharmacogenomics RIBEF. Céspedes-Garro C, et al. Rev Biol Trop. 2016 Sep;64(3):1067-76. doi: 10.15517/rbt.v64i3.20901. Rev Biol Trop. 2016. PMID: 29461783